Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

8 Insurance Stocks to Sell Now

This week, 8 Insurance stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Semiconductors & Semiconductor Equipment Stocks to Sell Now

The overall ratings of 5 Semiconductors & Semiconductor Equipment stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Commercial Services & Supplies Stocks to Sell Now

This week, 4 Commercial Services & Supplies stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Awful Earnings Momentum — CTRP SAEX GNK EGLE EMITF

This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

Comcast Corporation Does Best Wells Fargo & Co. Impression, Gets Slapped on the Wrist

Cable giant Comcast Corporation (NASDAQ:CMCSA) was hit with the largest cable fine in history after pulling a fast one on customers.

The Mylan NV (MYL) Stock Relief Rally Won’t Last Long

MYL stock is currently priced high on hopes that it can limit damage over the EpiPen and return to normal. But is this hope enough for Mylan?

4 Food & Staples Retailing Stocks to Sell Now

The overall ratings of 4 Food & Staples Retailing stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!

Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.

5 Stocks With Poor Earnings Growth — EMG SSY STFC SPWR HALO

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

4 Health Care Equipment & Supplies Stocks to Sell Now

The overall ratings of 4 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Biotechnology Stocks to Sell Now

This week, 6 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 IT Services Stocks to Sell Now

This week, the ratings of 5 IT Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Media Stocks to Sell Now

This week, the ratings of 5 Media stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

No One Else Wants Twitter Inc (TWTR) Stock. Why Do You?

Twitter stock is getting hammered on Monday as all bets for a buyout bid seem to be off. If you're still long TWTR, it's time to search your soul.

5 Stocks With Ugly Operating Margin — KONE SPLS EPE ENLC ARRY

This week, these five stocks have the worst ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

3 Retailers (Not Sears) That Are Likely to Go Bankrupt

The outlook for retailers is pretty grim right now. As a result, CEOs working in the industry face incredible pressure to deliver results today -- or else.

Tyson Foods, Inc. (TSN) Deep-Fried Over Antitrust Allegations

Analyst says the antitrust accusations against Tyson Foods (TSN) and others hold a lot of water, even if there's no smoking gun.

Yahoo! Inc. (YHOO) CEO Marissa Mayer’s Final Humiliation?

Just when owners of Yahoo stock though the debacle was over, another batch of Mayer's bad decisions hit YHOO at the worst possible time.

Why Chipotle Mexican Grill, Inc. (CMG) Won’t Bounce Back in 2017

Chipotle stock (CMG) has lost nearly half its value since the company poisoned more than 500 customers. Like its diners, investors won't return anytime soon.